Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2021  |  Volume : 34  |  Issue : 1  |  Page : 391-397

Comparison of choroidal thickness before and after injection of ranibizumab in patients with diabetic macular edema

1 Department of Ophthalmology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Department of Ophthalmology, Ophthalmology Hospital, Menoufia, Egypt

Correspondence Address:
Lamiaa T. M. Kashkoush
Shebin El-Kom, Menoufia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mmj.mmj_262_20

Rights and Permissions

Objective To compare choroidal thickness before and after injection of ranibizumab in patients with diabetic macular edema (DME) using enhanced depth optical coherence tomography (EDI-OCT). Background DME is one of the most common complications of diabetic retinopathy (DR) and the most common cause of visual impairment. Intravitreal injection of antivascular endothelial growth factor is currently the most commonly used procedure for the treatment of DME. Patients and methods A prospective clinical study was conducted on 30 eyes of 27 patients of DME who underwent intravitreal injection of ranibizumab. A complete history was taken from all cases, and a full ophthalmologic examination was done. Fluorescein angiography and EDI-OCT were performed before injection and also at 1 month after injection. The difference between preoperative and postoperative subfoveal choroidal thickness was calculated. Result The mean preoperative choroidal thickness measured subfoveally using EDI-OCT was 233.1 ± 20.22, whereas the mean of postoperative choroidal thickness after 1 month was 214.4 ± 19.61. The range of difference between preoperative and 1 month postoperative choroidal thickness using EDI-OCT was from 23 to 28 μm and the mean was 18.67 ± 8.99; the difference was calculated by subtracting the preoperative choroidal thickness from 1-month postoperative choroidal thickness. Conclusion There is a significant difference between the preoperative and 1-month postoperative choroidal thickness using EDI-OCT after injection of intravitreal ranibizumab in DME.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal